Literature DB >> 23308378

Effect of the Medicare face-to-face visit requirement on hospice utilization.

Joan Harrold1, Pam Harris, Dena Green, Teresa Craig, David J Casarett.   

Abstract

BACKGROUND: Although many patients enter hospice close to death, some enroll for more than six months. In 2011 the U.S. Centers for Medicare and Medicaid Services (CMS) required that these long-stay patients receive a face-to-face visit by a physician or nurse practitioner to ensure that they continue to meet eligibility criteria.
OBJECTIVES: This study proposed to determine whether the face-to-face visit requirement increased the rate at which patients were decertified from hospice.
DESIGN: The study was a retrospective cohort study in six U.S. hospices. Decertification from hospice within 10 months of enrollment was measured.
RESULTS: Of 23,638 patients, 11,788 (49.9%) would have been affected by the face-to-face requirement. In bivariate analysis, there was a significant decrease in the decertification rate after the requirement was implemented-371/11,788 (3.2%) versus 578/11,850 (4.9%); odds ration (OR): 0.63; 95% CI 0.55-0.72; p<0.001. In a multivariable logistic regression model adjusting for changes in patient characteristics and clustered by hospice, there was still a reduction in decertifications-3.4% versus 5.2%; OR 0.67; 95% CI 0.47-0.97; p=0.034. Although the impact of the face-to-face requirement varied among hospices, all hospices had a decrease in decertification rates (absolute adjusted reduction between 1.4% and 3.6%).
CONCLUSIONS: The face-to-face requirement may decrease hospice discharges, contrary to its intention.

Entities:  

Mesh:

Year:  2013        PMID: 23308378      PMCID: PMC3569924          DOI: 10.1089/jpm.2012.0349

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  8 in total

1.  Validity of the palliative performance scale from a survival perspective.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  J Pain Symptom Manage       Date:  1999-07       Impact factor: 3.612

2.  Association of hospice agency profit status with patient diagnosis, location of care, and length of stay.

Authors:  Melissa W Wachterman; Edward R Marcantonio; Roger B Davis; Ellen P McCarthy
Journal:  JAMA       Date:  2011-02-02       Impact factor: 56.272

3.  Length of survival in hospice for cancer patients referred from a comprehensive cancer center.

Authors:  Tallal Younis; Robert Milch; Nawal Abul-Khoudoud; David Lawrence; Amy Mirand; Ellis Levine
Journal:  Am J Hosp Palliat Care       Date:  2009-04-08       Impact factor: 2.500

4.  Palliative performance scale (PPS): a new tool.

Authors:  F Anderson; G M Downing; J Hill; L Casorso; N Lerch
Journal:  J Palliat Care       Date:  1996       Impact factor: 2.250

5.  Prognostication in hospice care: can the palliative performance scale help?

Authors:  Barbara Head; Christine S Ritchie; Tonya M Smoot
Journal:  J Palliat Med       Date:  2005-06       Impact factor: 2.947

6.  Is the palliative performance scale a useful predictor of mortality in a heterogeneous hospice population?

Authors:  Joan Harrold; Elizabeth Rickerson; Janet T Carroll; Jennifer McGrath; Knashawn Morales; Jennifer Kapo; David Casarett
Journal:  J Palliat Med       Date:  2005-06       Impact factor: 2.947

7.  Survival implications of sudden functional decline as a sentinel event using the palliative performance scale.

Authors:  G Michael Downing; Mary Lesperance; Francis Lau; Ju Yang
Journal:  J Palliat Med       Date:  2010-05       Impact factor: 2.947

8.  Predicting survival with the Palliative Performance Scale in a minority-serving hospice and palliative care program.

Authors:  Li-Chueh Weng; Hsiu-Li Huang; Diana J Wilkie; Noreen A Hoenig; Marie L Suarez; Michael Marschke; Jan Durham
Journal:  J Pain Symptom Manage       Date:  2008-09-26       Impact factor: 3.612

  8 in total
  1 in total

1.  Can hospices predict which patients will die within six months?

Authors:  Pamela S Harris; Tapati Stalam; Kevin A Ache; Joan E Harrold; Teresa Craig; Joan Teno; Eugenia Smither; Meredith Dougherty; David Casarett
Journal:  J Palliat Med       Date:  2014-06-12       Impact factor: 2.947

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.